open access

Vol 79, No 2 (2020)
LETTERS TO THE EDITOR
Published online: 2020-04-22
Submitted: 2020-02-27
Accepted: 2020-03-10
Get Citation

Considerations on the management of pyruvate dehydrogenase deficiency

J. Finsterer
DOI: 10.5603/FM.a2020.0046
·
Pubmed: 32329035
·
Folia Morphol 2020;79(2):415-416.

open access

Vol 79, No 2 (2020)
LETTERS TO THE EDITOR
Published online: 2020-04-22
Submitted: 2020-02-27
Accepted: 2020-03-10

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Considerations on the management of pyruvate dehydrogenase deficiency

Journal

Folia Morphologica

Issue

Vol 79, No 2 (2020)

Pages

415-416

Published online

2020-04-22

DOI

10.5603/FM.a2020.0046

Pubmed

32329035

Bibliographic record

Folia Morphol 2020;79(2):415-416.

Authors

J. Finsterer

References (14)
  1. Bruci A, Tuccinardi D, Tozzi R, et al. Very low-calorie ketogenic diet: a safe and effective tool for weight loss in patients with obesity and mild kidney failure. Nutrients. 2020; 12(2).
  2. DeBrosse SD, Okajima K, Zhang S, et al. Spectrum of neurological and survival outcomes in pyruvate dehydrogenase complex (PDC) deficiency: lack of correlation with genotype. Mol Genet Metab. 2012; 107(3): 394–402.
  3. Ebertowska A, Ludkiewicz B, Klejbor I, et al. Pyruvate dehydrogenase deficiency - morphological and metabolic effects, creation of animal model to study and research for treatment therapy. Folia Morphol. 2020 [Epub ahead of print].
  4. Finsterer J, Frank M. Low-Glycemic-Index Diet Relieving Migraine but Inducing Muscle Cramps. J Neurosci Rural Pract. 2019; 10(3): 552–554.
  5. Finsterer J, Zarrouk Mahjoub S. Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders. Expert Opin Drug Metab Toxicol. 2012; 8(1): 71–79.
  6. Giribaldi G, Doria-Lamba L, Biancheri R, et al. Intermittent-relapsing pyruvate dehydrogenase complex deficiency: a case with clinical, biochemical, and neuroradiological reversibility. Dev Med Child Neurol. 2012; 54(5): 472–476.
  7. Holecek M, Vodenicarovova M. Phenylbutyrate exerts adverse effects on liver regeneration and amino acid concentrations in partially hepatectomized rats. Int J Exp Pathol. 2016; 97(3): 278–284.
  8. Holeček M. Branched-chain amino acid supplementation in treatment of liver cirrhosis: Updated views on how to attenuate their harmful effects on cataplerosis and ammonia formation. Nutrition. 2017; 41: 80–85.
  9. Kaufmann P, Engelstad K, Wei Y, et al. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology. 2006; 66(3): 324–330.
  10. Lissens W, Vreken P, Barth PG, et al. Cerebral palsy and pyruvate dehydrogenase deficiency: identification of two new mutations in the E1alpha gene. Eur J Pediatr. 1999; 158(10): 853–857.
  11. Mu C, Corley MJ, Lee RWY, et al. Metabolic framework for the improvement of autism spectrum disorders by a modified ketogenic diet: a pilot study. J Proteome Res. 2020; 19(1): 382–390.
  12. Salih MA, Abdel-Gader AGM, Zahraa JN, et al. Stroke in Saudi children. Epidemiology, clinical features and risk factors. Saudi Med J. 2006; 27 Suppl 1: S12–S20.
  13. Spiegler J, Stefanova I, Hellenbroich Y, et al. Bowel obstruction in patients with Alpers-Huttenlocher syndrome. Neuropediatrics. 2011; 42(5): 194–196.
  14. Vitale G, Simonetti G, Pirillo M, et al. Bipolar and Related Disorders Induced by Sodium 4-Phenylbutyrate in a Male Adolescent with Bile Salt Export Pump Deficiency Disease. Psychiatry Investig. 2016; 13(5): 580–582.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By  "Via Medica sp. z o.o." sp.k., Świętokrzyska 73, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl